Research on Novel Targets and Potential Risk Factors Drives Improvements in the Management of GI Cancers

Gastrointestinal oncology experts discuss current strategies and novel developments in gastrointestinal cancers, the role of intestinal dysbiosis and gastrointestinal carcinogenesis, germline genetic features in appendiceal cancer, and the need for anticipatory, multidisciplinary guidance in clinical practice.

Related Keywords

Jordan ,United States ,Vanderbilt University ,Tennessee ,Brianc Grieb ,Rajiv Agarwal ,Kristen Ciombor ,Cathy Eng ,Michael Lidsky ,Michaelk Gibson ,Danab Cardin ,Davidh Johnson ,Mariana Xavier Byndloss ,Laura Goff ,Sekhar Padmanabhan ,Vanderbilt Ingram Cancer Center ,Patient Care Center ,Memorial Sloan Kettering Cancer Center ,Division Of Hematology Oncology ,Department Of Surgery ,Department Of Medicine ,Phasei Program In Gastrointestinal Malignancies ,Division Of Surgical Oncology Endocrine Surgery ,Safety Monitoring Committee ,Gibson ,Gastrointestinal Steering Committee ,Vanderbilt Health ,Translational Research In Head ,Young Adults Program ,Gastrointestinal Cancer Research Program ,Duke Health ,Vanderbilt University Medical Center ,Ingram Professor Of Cancer Research ,Division Of Hematology ,Science Summit ,Endowed Chair ,Medical Oncology ,Adults Program ,Steering Committee ,Translational Research ,Neck Oncology ,Xavier Byndloss ,Surgical Oncology ,Endocrine Surgery ,Care Center ,Ingram Professor ,Cancer Research ,Phasei Program ,Gastrointestinal Malignancies ,Clinical Trials ,Directed Options May Personalize ,Treatment Landscape ,Link Between Intestinal Dysbiosis ,Potential Role ,Germline Genetic Features ,Appendix Cancer ,Provides More Widespread Benefit ,Target Actionable Genomic Biomarkers ,Hepatic Artery Infusion ,Spark Debate ,Upper East ,Shift Treatment Paradigm ,Biliary Tract ,Supportive Care ,Clinical Practice ,Improving Patient Outcomes ,